Published:2020 Dec 20
Source:Diving and hyperbaric medicine (Diving Hyperb Med), volume 50, issue 4, 2020, ISSN: 1833-3516
Publication Type:Journal Article, Observational Study
Keywords:Age, Data, Haematology, Middle ear, Risk factors, Women
MeSH Terms:Anticoagulants (adverse effects); Barotrauma (epidemiology, etiology, therapy); Ear, Middle; Female; Humans; Hyperbaric Oxygenation; Male; Oxygen; Retrospective Studies; Tympanic MembraneTitle
INTRODUCTION: Middle ear barotrauma (MEBt) is a common side effect of hyperbaric oxygen treatment (HBOT) and can result in pain, hearing loss, tinnitus and otorrhagia. The use of antiplatelet/anticoagulant drugs is thought to increase the risk and severity of MEBt during HBOT.
Categories: DPC News